Lv1
68 积分 2023-04-03 加入
Discovery of a High-Potency Balanced GLP-1/GIP Dual Agonist by Molecular Dynamics Evolution
5天前
已完结
Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections
18天前
已关闭
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
2个月前
已完结
Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist
2个月前
已完结
Meta-analysis for alterations of IFN-γ, TNF-α and granzyme B levels in vitiligo patients
2个月前
已完结
Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte
2个月前
已完结
Cell-penetrating peptides for therapeutic applications: emerging design strategies and future directions
3个月前
已完结
The case for cell-penetrating peptides
3个月前
已完结
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges
3个月前
已完结
The evolution of the obesity drug market
3个月前
已完结
皖公网安备34019202002308
